Search results

The PharmEco Group of Companies will build a pharmaceutical manufacturing facility for oncology treatments in Chernogolovka, Moscow Region, by 2030. The total investment in the project is estimated at 9.1 billion rubles. A trilateral agreement was signed during the St. Petersburg International Economic Forum (SPIEF 2025) between the Ministry of Investment, Industry and Science of…

The Russian government has approved updated regulations governing the release of medicines into civil circulation. The new rules cover: Various versions of the draft regulation were published by the Ministry of Health in January and February 2025. The newly adopted procedure replaces the 2019 regulation, which was originally set to expire in September 2025. The…

The Russian government has amended its decree on measures for granting national treatment in the procurement of goods, works, and services for state and municipal needs. The original document, adopted in late December 2024, extended the “third-party exclusion” mechanism (“the second extra one”) to the purchase of medicines from the list of vital and essential…

From January to April 2025, medicine sales in Russia reached 1.03 trillion rubles. Compared to the same period in 2024, this represents a 17% increase. In physical volume, however, the market grew by only 2%, with 1.92 billion packages sold. According to a report by the analytics company AlphaRM, the pharmaceutical market exceeded 1 trillion…

Pfizer CEO Albert Bourla has called on European countries to increase their spending on medicines. He proposed setting a fixed percentage of GDP per capita for such expenditures, similar to NATO’s defense spending commitments. Speaking at the annual Goldman Sachs healthcare conference, Bourla urged developed countries to boost funding for innovative drugs. The text of…

The Russian government has granted Geropharm permission to use, without the patent holder’s consent, a portfolio of patents protecting Novo Nordisk’s exclusive rights to semaglutide until the end of 2025. Similar decisions had previously been made for two other Russian companies — PSK Pharma and Promomed — in late 2024. Geropharm had already been covered…

On Tuesday, the State Duma passed in the first reading a government-sponsored bill introducing administrative liability for drivers who operate vehicles under the influence of certain medications. Bill No. 379447-8 proposes amendments to Articles 12.8 and 12.27 (Part 3) of the Russian Code of Administrative Offenses (KoAP), expanding the scope of punishable intoxication. Under the…

The Federal Antimonopoly Service (FAS) of Russia plans to investigate several domestic pharmaceutical companies due to signs of unjustified price increases for drugs not included in the list of vital and essential medicines (VED). This was announced by Timofey Nizhegorodtsev, Deputy Head of the FAS, during the Semashko Russian Pharmaceutical Forum. “Many companies may soon…

The discovery could greatly reduce chemotherapy toxicity and change future approaches to cancer treatment. Scientists at Ural Federal University (UrFU) have created carbene-based platinum complexes that suppress tumor cell growth ten times more effectively than cisplatin — one of the most widely used chemotherapy drugs. The discovery could help fight tumors that have developed resistance…

At the Semashko Russian Pharmaceutical Forum, domestic and international pharmaceutical companies gathered to discuss fair mechanisms for determining the level of localization in drug manufacturing and what support measures could help the industry invest more in development. Russia’s Ministry of Industry and Trade (Minpromtorg), the sector’s key regulator, reminded participants that it is currently working…